Johns Hopkins University behavioral biology professor Roland Griffiths struggles with the same ethical questions when he studies the chemicals behind hallucinogenic mushrooms.
Rather than a traditional trial setup, his patients pay tens of thousands of dollars for the privilege of participating in the studies (not the most ethical or effective subject selection strategy).